Which biologic agents increase perioperative complications in patients with inflammatory bowel disease?

被引：1
|
作者：
Park, Jihye [1 ,2 ]
机构：
[1] Yonsei Univ, Dept Internal Med, Coll Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Inst Gastroenterol, Coll Med, Seoul, South Korea
来源：
INTESTINAL RESEARCH | 2022年 / 20卷 / 01期
关键词：
NECROSIS FACTOR THERAPY; CROHNS-DISEASE; RISK-FACTORS; SURGERY; VEDOLIZUMAB;
D O I：
10.5217/ir.2021.00170
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：1 / 2
页数：2
相关论文
共 50 条
  • [31] Biologic therapy for inflammatory bowel disease
    Sands, BE
    INFLAMMATORY BOWEL DISEASES, 1997, 3 (02) : 95 - 113
  • [32] Biologic therapy of inflammatory bowel disease
    Baumgart, DC
    Wiedenmann, B
    Dignass, AU
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2003, 41 (10): : 1017 - 1032
  • [33] The Influence of the Introduction of Biologic Agents on Surgical Intervention in Paediatric Inflammatory Bowel Disease
    Bethell, George S.
    Ashton, James J.
    Adams, Stephen
    Beattie, R. Mark
    Hall, Nigel J.
    Stanton, Michael P.
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2022, 75 (03) : 308 - 312
  • [34] Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease
    Haas, Leonard
    Chevalier, Rachel
    Major, Brittny T.
    Enders, Felicity
    Kumar, Seema
    Tung, Jeanne
    DIGESTIVE DISEASES AND SCIENCES, 2017, 62 (11) : 3110 - 3116
  • [35] Safety of Combination Biologic and Antirejection Therapy Post-Liver Transplantation in Patients With Inflammatory Bowel Disease
    Al Draiweesh, Saleh
    Ma, Christopher
    Alkhattabi, Maan
    McDonald, Cassandra
    Nguyen, Tran M.
    Beaton, Melanie
    Chande, Nilesh
    Colquhoun, Patrick
    Feagan, Brian G.
    Gregor, James C.
    Khanna, Reena
    Marotta, Paul
    Ponich, Terry
    Quan, Douglas
    Qumosani, Karim
    Sandhu, Amindeep
    Sey, Michael
    Skaro, Anton
    Teriaky, Anouar
    Wilson, Aze
    Yan, Brian
    Brahmania, Mayur
    Jairath, Vipul
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (06) : 949 - 959
  • [36] Inflammatory bowel disease surgery in the biologic therapy era
    Strong, Scott A.
    CURRENT OPINION IN GASTROENTEROLOGY, 2012, 28 (04) : 349 - 353
  • [37] The Role of Early Biologic Therapy in Inflammatory Bowel Disease
    Berg, Dana Rachel
    Colombel, Jean-Frederic
    Ungaro, Ryan
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (12) : 1896 - 1905
  • [38] Biologic Agents Are Associated with Excessive Weight Gain in Children with Inflammatory Bowel Disease
    Leonard Haas
    Rachel Chevalier
    Brittny T. Major
    Felicity Enders
    Seema Kumar
    Jeanne Tung
    Digestive Diseases and Sciences, 2017, 62 : 3110 - 3116
  • [39] The Effect of Biologics on Postoperative Complications in Children With Inflammatory Bowel Disease and Bowel Resection
    Mitsuya, Jennifer B.
    Gonzalez, Raquel
    Thomas, Ron
    El-Baba, Mohammad
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2019, 68 (03) : 334 - 338
  • [40] Home vs Hospital Infusion of Biologic Agents for Patients With Inflammatory Bowel Diseases
    Fenster, Marc
    Ungaro, Ryan C.
    Hirten, Robert
    Gallinger, Zane
    Cohen, Louis
    Atreja, Ashish
    Mehandru, Saurabh
    Colombel, Jean-Frederic
    Cohen, Benjamin L.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2020, 18 (01) : 257 - 258
12345